BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 32320700)

  • 41. Gold induces a pseudo-allergic reaction via MRGPRX2 both in vitro and in vivo.
    Zeng Y; Wang J; Zhang Y; Ge S; Wu Y; Fan T; Wang N
    Cell Immunol; 2019 Jul; 341():103923. PubMed ID: 31076078
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A mast-cell-specific receptor mediates Iopamidol induced immediate IgE-independent anaphylactoid reactions.
    Jiang W; Hu S; Che D; An H; Liu R
    Int Immunopharmacol; 2019 Oct; 75():105800. PubMed ID: 31401386
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inflamed Ulcerative Colitis Regions Associated With MRGPRX2-Mediated Mast Cell Degranulation and Cell Activation Modules, Defining a New Therapeutic Target.
    Chen E; Chuang LS; Giri M; Villaverde N; Hsu NY; Sabic K; Joshowitz S; Gettler K; Nayar S; Chai Z; Alter IL; Chasteau CC; Korie UM; Dzedzik S; Thin TH; Jain A; Moscati A; Bongers G; Duerr RH; Silverberg MS; Brant SR; Rioux JD; Peter I; Schumm LP; Haritunians T; McGovern DP; Itan Y; Cho JH
    Gastroenterology; 2021 Apr; 160(5):1709-1724. PubMed ID: 33421512
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mast cell degranulation via MRGPRX2 by isolated human albumin fragments.
    Karhu T; Akiyama K; Vuolteenaho O; Bergmann U; Naito T; Tatemoto K; Herzig KH
    Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2530-2534. PubMed ID: 28844982
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis of unnatural morphinan compounds to induce itch-like behaviors in mice: Towards the development of MRGPRX2 selective ligands.
    Iio K; Kutsumura N; Nagumo Y; Saitoh T; Tokuda A; Hashimoto K; Yamamoto N; Kise R; Inoue A; Mizoguchi H; Nagase H
    Bioorg Med Chem Lett; 2022 Jan; 56():128485. PubMed ID: 34861349
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GRK2 differentially regulates FcεRI and MRGPRB2-mediated responses in mast cells.
    Thapaliya M; Ali H
    Front Immunol; 2023; 14():1155777. PubMed ID: 37063868
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amelioration of Compound 48/80-Mediated Itch and LL-37-Induced Inflammation by a Single-Stranded Oligonucleotide.
    Dondalska A; Rönnberg E; Ma H; Pålsson SA; Magnusdottir E; Gao T; Adam L; Lerner EA; Nilsson G; Lagerström M; Spetz AL
    Front Immunol; 2020; 11():559589. PubMed ID: 33101278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dual effect of tacrolimus on mast cell-mediated allergy and inflammation through Mas-related G protein-coupled receptor X2.
    Du X; Che D; Peng B; Zheng Y; Hao Y; Jia T; Zhang X; Geng S
    J Dermatol Sci; 2023 Dec; 112(3):128-137. PubMed ID: 37953179
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MrgX2 is a promiscuous receptor for basic peptides causing mast cell pseudo-allergic and anaphylactoid reactions.
    Grimes J; Desai S; Charter NW; Lodge J; Moita Santos R; Isidro-Llobet A; Mason AM; Wu Z; Wolfe LA; Anantharaman L; Green A; Bridges AM; Dalmas Wilk DA; Brown AJ
    Pharmacol Res Perspect; 2019 Dec; 7(6):e00547. PubMed ID: 31832205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tachykinin-1 receptor antagonism suppresses substance-P- and compound 48/80-induced mast cell activation from rat mast cells expressing functional mas-related GPCR B3.
    Sahid MNA; Liu S; Mogi M; Maeyama K
    Inflamm Res; 2020 Mar; 69(3):289-298. PubMed ID: 31993675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dextromethorphan - A widely-used cough suppressant - Induces local anaphylaxis via MRGPRX2 on mast cells.
    Hu T; Hou Y; Lu J; Wang X; Wei D; Wang C
    Chem Biol Interact; 2020 Oct; 330():109248. PubMed ID: 32871113
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The anti-anaphylactoid effects of Piperine through regulating MAS-related G protein-coupled receptor X2 activation.
    Qiao C; Hu S; Che D; Wang J; Gao J; Ma R; Jiang W; Zhang T; Liu R
    Phytother Res; 2020 Jun; 34(6):1409-1420. PubMed ID: 31989711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mas-Related G Protein-Coupled Receptor-X2 (MRGPRX2) in Drug Hypersensitivity Reactions.
    Porebski G; Kwiecien K; Pawica M; Kwitniewski M
    Front Immunol; 2018; 9():3027. PubMed ID: 30619367
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In silico design of novel probes for the atypical opioid receptor MRGPRX2.
    Lansu K; Karpiak J; Liu J; Huang XP; McCorvy JD; Kroeze WK; Che T; Nagase H; Carroll FI; Jin J; Shoichet BK; Roth BL
    Nat Chem Biol; 2017 May; 13(5):529-536. PubMed ID: 28288109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel MRGPRX2 antagonists inhibit IgE-independent activation of human umbilical cord blood-derived mast cells.
    Ogasawara H; Furuno M; Edamura K; Noguchi M
    J Leukoc Biol; 2019 Nov; 106(5):1069-1077. PubMed ID: 31299111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between mutated Mas-related G protein-coupled receptor-X2 and rocuronium-induced intraoperative anaphylaxis.
    Suzuki Y; Liu S; Kadoya F; Takasaki Y; Yorozuya T; Mogi M
    Br J Anaesth; 2020 Dec; 125(6):e446-e448. PubMed ID: 32622467
    [No Abstract]   [Full Text] [Related]  

  • 57. Ligands and Signaling of Mas-Related G Protein-Coupled Receptor-X2 in Mast Cell Activation.
    Mi YN; Ping NN; Cao YX
    Rev Physiol Biochem Pharmacol; 2021; 179():139-188. PubMed ID: 33479839
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Substance P analogs devoid of key residues fail to activate human mast cells
    Raj S; Hlushak S; Arizmendi N; Kovalenko A; Kulka M
    Front Immunol; 2023; 14():1155740. PubMed ID: 37228611
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multifaceted MRGPRX2: New insight into the role of mast cells in health and disease.
    Roy S; Chompunud Na Ayudhya C; Thapaliya M; Deepak V; Ali H
    J Allergy Clin Immunol; 2021 Aug; 148(2):293-308. PubMed ID: 33957166
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A phytosphingosine derivative mYG-II-6 inhibits histamine-mediated TRPV1 activation and MRGPRX2-dependent mast cell degranulation.
    Adhikari N; Lee WJ; Park S; Kim S; Shim WS
    Int Immunopharmacol; 2024 May; 133():112113. PubMed ID: 38657498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.